MEN1 is a regulator of alternative splicing and prevents R-loop-induced genome instability through suppression of RNA polymerase II elongation

• Published in: Nucleic acids research 2023-08, Vol.51 (15), p.7951-7971
• Main Authors: Jin, Bangming, Zhu, Jiamei, Pan, Ting, Yang, Yunqiao, Liang, Li, Zhou, Yuxia, Zhang, Tuo, Teng, Yin, Wang, Ziming, Wang, Xuyan, Tian, Qianting, Guo, Bing, Li, Haiyang, Chen, Tengxiang
• Format: Article
• Language: English
• Subjects: Genome Integrity, Repair and
• ISSN: 0305-1048; 1362-4962
• DOI: 10.1093/nar/gkad548

Abstract The fidelity of alternative splicing (AS) patterns is essential for growth development and cell fate determination. However, the scope of the molecular switches that regulate AS remains largely unexplored. Here we show that MEN1 is a previously unknown splicing regulatory factor. MEN1 deletion resulted in reprogramming of AS patterns in mouse lung tissue and human lung cancer cells, suggesting that MEN1 has a general function in regulating alternative precursor mRNA splicing. MEN1 altered exon skipping and the abundance of mRNA splicing isoforms of certain genes with suboptimal splice sites. Chromatin immunoprecipitation and chromosome walking assays revealed that MEN1 favored the accumulation of RNA polymerase II (Pol II) in regions encoding variant exons. Our data suggest that MEN1 regulates AS by slowing the Pol II elongation rate and that defects in these processes trigger R-loop formation, DNA damage accumulation and genome instability. Furthermore, we identified 28 MEN1-regulated exon-skipping events in lung cancer cells that were closely correlated with survival in patients with lung adenocarcinoma, and MEN1 deficiency sensitized lung cancer cells to splicing inhibitors. Collectively, these findings led to the identification of a novel biological role for menin in maintaining AS homeostasis and link this role to the regulation of cancer cell behavior. Graphical Abstract Graphical Abstract